Literature DB >> 24735713

Cystic fibrosis, a multi-systemic mucosal disease: 25 years after the discovery of CFTR.

Aleksander Edelman1, Jean-Michel Sallenave2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24735713     DOI： 10.1016/j.biocel.2014.04.006

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN： 1357-2725            Impact factor:   5.085


× No keyword cloud information.
  4 in total

1.  Pseudomonas Aeruginosa Lung Infection Subverts Lymphocytic Responses through IL-23 and IL-22 Post-Transcriptional Regulation.

Authors:  Bérengère Villeret; Reem Ghinnagow; Saadé Kheir; Maëlys Born-Bony; Jay K Kolls; Ignacio Garcia-Verdugo; Jean-Michel Sallenave
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

2.  IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections.

Authors:  Saadé Kheir; Bérengère Villeret; Ignacio Garcia-Verdugo; Jean-Michel Sallenave
Journal:  Mol Ther       Date:  2021-08-08       Impact factor: 11.454

Review 3.  The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.

Authors:  Marta Stolarczyk; Bob J Scholte
Journal:  Mediators Inflamm       Date:  2018-01-09       Impact factor: 4.711

4.  Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation.

Authors:  Fabien Bastaert; Saadé Kheir; Vinciane Saint-Criq; Bérengère Villeret; Pham My-Chan Dang; Jamel El-Benna; Jean-Claude Sirard; Romé Voulhoux; Jean-Michel Sallenave
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.